Biotum 1gm Injection

Biotum 1gm Injection contains ceftazidime as its active ingredient. It is an antibiotic belonging to the cephalosporin class of drugs. This medication demonstrates broad-spectrum activity against Gram-negative bacteria, including Pseudomonas aeruginosa, Klebsiella species, Escherichia coli, Proteus species, and others. It is used to treat various bacterial infections caused by susceptible organisms, including lower respiratory tract infections, skin and skin structure infections, bone and joint infections, urinary tract infections, gynaecological infections, bacterial septicaemia, abdominal infections, and central nervous system infections caused by various bacterial strains. This medicine may be combined with other antibiotics to produce synergistic effects and enhance treatment effectiveness in certain cases. Patients with known allergy to cephalosporin antibiotics or penicillin antibiotics carry an increased risk of allergic reactions to Biotum 1gm Injection. The drug is primarily excreted through the kidneys. Patients with impaired kidney function may require dose adjustments or close monitoring to prevent potential side effects or toxicity. This medication can cause gastrointestinal disturbances such as diarrhoea, colitis, or pseudomembranous colitis. Patients with a history of gastrointestinal diseases require close monitoring during treatment with this medication. Some formulations of Biotum 1gm Injection may contain ingredients not recommended for use in newborns and infants. Consultation with a paediatrician is advised before administering any medication to young children.

Biotum 1gm Injection is used to treat the following: Respiratory tract infections Urinary tract infections Bone and joint infections Gynecologic infections Skin infections Abdominal infections Bacterial septicemia Infections in the nervous system

The therapeutic effect of Biotum 1gm Injection is its ability to effectively treat a wide range of serious bacterial infections, particularly those caused by Gram-negative bacteria. As a potent and broad-spectrum cephalosporin antibiotic, this medication works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Its bactericidal action makes it a crucial choice in combating infections like complicated intra-abdominal infections, hospital-acquired pneumonia, bloodstream infections, urinary tract infections, and certain skin and soft tissue infections. Its intravenous formulation allows for rapid delivery and steady blood levels, making it well-suited for severe infections requiring immediate treatment.

Biotum 1gm Injection is typically administered via injections in hospital settings by a healthcare professional. The dosage and frequency of administration depend on the severity of the infection, the patient's age, and kidney function.

Biotum 1gm Injection causes some side effects like all medications, although not everyone will experience them. Serious: Severe allergic reactions Severe skin reactions Clostridium difficile-associated diarrhea Liver problems (jaundice, dark urine, and persistent abdominal pain) Decreased urine output Swelling in the legs or ankles Changes in urination frequency Common: Nausea Vomiting Diarrhea Rash Itching Pain or inflammation at the injection site (for intravenous use) Headache Fever

Patients with a history of allergies to cephalosporin or penicillin antibiotics should inform their healthcare provider to avoid potential allergic reactions. It is essential to complete the full course of treatment as prescribed, even if symptoms improve, to prevent antibiotic resistance. Biotum 1gm Injection can disrupt normal gut flora, leading to Clostridium difficile-associated diarrhea, so any signs of persistent diarrhea should be reported to the healthcare provider. Patients with impaired kidney or liver function may require dose adjustments or close monitoring. Since this medication can affect electrolyte levels, careful monitoring may be necessary, especially in high-risk patients. Use during pregnancy and breastfeeding requires careful evaluation by a healthcare professional to balance potential risks and benefits. Caution should be exercised in patients with central venous catheters to prevent catheter-related infections. Patients should promptly report any unusual or severe side effects to their healthcare provider.